Gateway Traditional Grant Program supports researchers at institutions worldwide to conduct early-phase cancer treatment trials that center patients and could change the standard of care.
The Joint Society for Integrative Oncology (SIO) Program supports SIO investigators and institutions conducting patient-centered clinical trials to strengthen evidence for integrative cancer care.
The Joint NCI/SPORE/P20 Program supports SPORE and P20 awardees in expanding clinical trials to advance patient-centric translational cancer research without duplicating SPORE-funded work.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
The Decentralized Clinical Trial Initiative (DCTI) supports oncology trial teams conducting technology-informed treatment studies that bring investigational care closer to patients, ideally at home.